Purchase Order 36C25821P0134
Award Date 3/18/21
Potential Completion Date 7/16/21
Potential Value $130K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
- This is a $6,891.78 firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH) to Lakepharma, Inc., a minority-owned, for-profit contract development and manufacturing organization (CDMO). The contract is for expression optimization and immunoaffinity capture (IMAC) pulldown services to support NIMH's internal research. The contract has a period of performance through September 9, 2025. There was no set-aside used for this award. Lakepharma has previously...
- The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order to Tri-Pharma, Inc., a minority-owned, small disadvantaged business, for the supply of ALBUMIN 5% 250ML. The $78,000.00 contract was awarded on April 13, 2015, with an ultimate completion date of October 30, 2015. Tri-Pharma is a pharmaceutical and medical supply company that has provided a range of products to various federal agencies, including the VA, Department of Health and Human Services, and...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order contract to Tri-Pharma, Inc., a minority-owned small disadvantaged business, to provide pharmaceuticals. The $698,425.00 contract has a completion date of June 3, 2019 and does not include a set-aside designation. Tri-Pharma is a specialty pharmaceutical wholesaler that has provided products such as RYDAPT tablets, fludarabine, and ranitidine to VA medical centers and the NIH Clinical...
- The U.S. Department of Veterans Affairs (VA) awarded a $5,779.20 firm-fixed-price purchase order to Hygen Pharmaceuticals Inc., a minority-owned small business certified as an 8(a) Program participant. The contract (36C77024P0271) is to provide an 11-line pharmaceutical requirement for the VA's Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP). This award is set aside for small businesses and is part of the VA's efforts to support socioeconomic contracting goals. Hygen Pharmaceuticals...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $227,739.71 firm fixed price purchase order to One Lambda, Inc., a for-profit manufacturer of medical diagnostics products, for the supply of tissue typing reagents. One Lambda has previously supported federal agencies such as the Department of Health and Human Services, Department of Veterans Affairs, and Department of Defense with specialized diagnostics capabilities for research, clinical care, and public health...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $131,040.00 firm fixed price purchase order contract to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract is to supply various pharmaceutical products including losartan potassium tablets, lamivudine/zidovudine combination tablets, lacosamide injections, and dutasteride capsules to support the VA's...
- This federal contract award, valued at $77,097.16, was issued by the U.S. Department of Veterans Affairs (VA) Network Contracting Office 15 to Hygen Pharmaceuticals Inc., a small, minority-owned business based in Redmond, Washington. The contract is a firm-fixed-price purchase order for the delivery of various pharmaceutical products, including thyroid medications, acamprosate tablets, and injection syringes, to the VA's Consolidated Mail Outpatient Pharmacy (CMOP) facilities in the VA's VISN 15...
- This is a $42,508.80 firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 15 to Hygen Pharmaceuticals Inc., a minority-owned small business in Redmond, Washington. The contract is set aside for small businesses and covers the supply of various pharmaceutical products, including thyroid medications, acamprosate tablets, dextrose solutions, ophthalmic solutions, and other prescription drugs, to multiple VA Consolidated Mail Outpatient...
- This $241,920.00 firm-fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business. The contract is for the delivery of pharmaceuticals such as RYDAPT tablets, fludarabine, and ranitidine to VA Medical Centers. Tri-Pharma has previously provided medical supplies and personal protective equipment to the VA and other federal agencies under similar prime...
The Department of Veterans Affairs Veterans Health Administration awarded a $130,145 firm-fixed-price purchase order to Lakepharma, Inc., a minority-owned, Asian-Pacific American-owned for-profit organization, to provide antibody humanization services. Lakepharma is a Contract Development and Manufacturing Organization (CDMO) that has previously supported federal agencies' medical research and healthcare missions through past contract awards for services such as affinity maturation, reagent production, monoclonal antibody development, DNA scale-up, and expression optimization. This contract does not have a set-aside designation and is focused on supporting the VA's biopharmaceutical development and manufacturing needs.
Generated 3/22/24, 4:08 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $130.1k | 3/18/21 |